IM Cannabis Balance Sheet Health

Financial Health criteria checks 3/6

IM Cannabis has a total shareholder equity of CA$4.2M and total debt of CA$15.2M, which brings its debt-to-equity ratio to 360.3%. Its total assets and total liabilities are CA$44.6M and CA$40.4M respectively.

Key information

360.3%

Debt to equity ratio

CA$15.17m

Debt

Interest coverage ration/a
CashCA$1.96m
EquityCA$4.21m
Total liabilitiesCA$40.43m
Total assetsCA$44.64m

Recent financial health updates

Recent updates

IM Cannabis Shareholder Rafael Gabay raises stake

Sep 08

IM Cannabis GAAP EPS of -C$0.30, revenue of C$23.8M

Aug 15

IM Cannabis receives non-compliance notification from Nasdaq for minimum bid price requirement

Jul 19

cbdMD And IM Cannabis Partner To Sell CBD Products In Israeli Markets

Aug 14

IM Cannabis proposes public offering of securities

May 05

IM Cannabis acquires Israel's largest retail and online pharmacy business from Panaxia

Apr 30

Financial Position Analysis

Short Term Liabilities: IMCC's short term assets (CA$27.6M) do not cover its short term liabilities (CA$39.2M).

Long Term Liabilities: IMCC's short term assets (CA$27.6M) exceed its long term liabilities (CA$1.2M).


Debt to Equity History and Analysis

Debt Level: IMCC's net debt to equity ratio (313.8%) is considered high.

Reducing Debt: IMCC's debt to equity ratio has increased from 0% to 360.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable IMCC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: IMCC is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 0.1% per year.


Discover healthy companies